Serina Therapeutics (SER) Leases (2019 - 2025)
Historic Leases for Serina Therapeutics (SER) over the last 5 years, with Q3 2025 value amounting to $312000.0.
- Serina Therapeutics' Leases fell 3870.33% to $312000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $312000.0, marking a year-over-year decrease of 3870.33%. This contributed to the annual value of $461000.0 for FY2024, which is 3078.08% down from last year.
- Latest data reveals that Serina Therapeutics reported Leases of $312000.0 as of Q3 2025, which was down 3870.33% from $362000.0 recorded in Q2 2025.
- Serina Therapeutics' 5-year Leases high stood at $666000.0 for Q4 2023, and its period low was $312000.0 during Q3 2025.
- Moreover, its 3-year median value for Leases was $485000.0 (2024), whereas its average is $488875.0.
- As far as peak fluctuations go, Serina Therapeutics' Leases crashed by 3078.08% in 2024, and later plummeted by 3870.33% in 2025.
- Over the past 3 years, Serina Therapeutics' Leases (Quarter) stood at $666000.0 in 2023, then plummeted by 30.78% to $461000.0 in 2024, then tumbled by 32.32% to $312000.0 in 2025.
- Its Leases was $312000.0 in Q3 2025, compared to $362000.0 in Q2 2025 and $412000.0 in Q1 2025.